Delivery Order SPE2DB22D3301-SPE2DB24FZ0BL

Award Date 7/8/24
Potential Completion Date 7/29/24
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tafinlar (50 mg capsules). The contract has a firm fixed price of $30,424.90 and a performance period ending on May 22, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication TAFINLAR 75 MG CAPSULE 120S. The contract has a ceiling value of $8,896.41 and is a firm fixed-price delivery order with a completion date of June 9, 2025. The contract is not set-aside and was awarded on May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAFINLAR 50 MG CAPSULE 120S, a pharmaceutical product. The contract is a delivery order with a firm fixed price of $13,836.26 and a completion date of June 30, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a $17,792.82 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication TAFINLAR 75 MG CAPSULE 120S, with a period of performance through July 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564512988 TAFINLAR 50 MG CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $12,627.74, is a Delivery Order under a Firm Fixed Price contract type. The award has no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the larger Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,321.30 order is for the delivery of TAFINLAR 50 MG CAPSULES 120S, a pharmaceutical product, to support DLA Troop Support Medical programs and facilities. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to supply pharmaceuticals,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of a variety of pharmaceutical products and medical supplies. The contract has a firm fixed price, with a ceiling value of $4,028.56, and a period of performance through May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs. The contract has a ceiling value of $138,647.84 and a period of performance through June 10, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition....
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to supply a range of medical and pharmaceutical products to support federal healthcare programs. The contract has a ceiling value of $12,090.00 and is a firm fixed-price delivery order with a completion date of June 10, 2025. The contract is not set aside and allows for the provision of both brand-name and generic medications across various...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,739.95 and covers the delivery of a range of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is a firm fixed-price, non-set-aside arrangement...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ0BL
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tafinlar 75 mg capsules. The contract has a ceiling value of $8,139.33 and a performance period through July 29, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation.

Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999.00 and $750,000.00 respectively, to provide a wide range of pharmaceutical products and medical supplies to various federal agencies and military treatment facilities. These IDCs serve as the primary vehicles for Amerisourcebergen to deliver essential medications, specialty drugs, and critical care materials to support the government's medical needs.

Generated 10/7/24, 10:56 AM